Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice
Identifieur interne : 000727 ( Main/Exploration ); précédent : 000726; suivant : 000728Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice
Auteurs : Jens Clausen [Allemagne]Source :
- European Journal of Neuroscience [ 0953-816X ] ; 2010-10.
English descriptors
- KwdEn :
Abstract
Deep brain stimulation (DBS) is a clinically established procedure for treating severe motor symptoms in patients suffering from end‐stage Parkinson’s disease, dystonia and essential tremor. Currently, it is tested for further indications including psychiatric disorders like major depression and a variety of other diseases. However, ethical issues of DBS demand continuing discussion. Analysing neuroethical and clinical literature, five major topics concerning the ethics of DBS in clinical practice were identified: thorough examination and weighing of risks and benefits; selecting patients fairly; protecting the health of children in paediatric DBS; special issues concerning patients’ autonomy; and the normative impact of quality of life measurements. In exploring DBS for further applications, additionally, issues of research ethics have to be considered. Of special importance in this context are questions such as what additional value is generated by the research, how to realise scientific validity, which patients should be included, and how to achieve an acceptable risk–benefit ratio. Patients’ benefit is central for ethical evaluation. This criterion can outweigh very serious side‐effects, and can make DBS appropriate even in paediatrics. Because standard test procedures evade central aspects of patients’ benefits, measuring quality of life should be supplemented by open in‐depth interviews to provide a more adequate picture of patients’ post‐surgical situation. To examine its entire therapeutic potential, further research in DBS is needed. Studies should be based on solid scientific hypotheses and proceed cautiously to benefit severely suffering patients without putting them to undue risks.
Url:
DOI: 10.1111/j.1460-9568.2010.07421.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice</title>
<author><name sortKey="Clausen, Jens" sort="Clausen, Jens" uniqKey="Clausen J" first="Jens" last="Clausen">Jens Clausen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:317B8452C4821DA8B3C152129AE149B83836055B</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1111/j.1460-9568.2010.07421.x</idno>
<idno type="url">https://api.istex.fr/document/317B8452C4821DA8B3C152129AE149B83836055B/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001A11</idno>
<idno type="wicri:Area/Main/Curation">001756</idno>
<idno type="wicri:Area/Main/Exploration">000727</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice</title>
<author><name sortKey="Clausen, Jens" sort="Clausen, Jens" uniqKey="Clausen J" first="Jens" last="Clausen">Jens Clausen</name>
<affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>University of Tübingen, Institute for Ethics and History in Medicine, Gartenstr. 47, 72074 Tübingen</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">European Journal of Neuroscience</title>
<idno type="ISSN">0953-816X</idno>
<idno type="eISSN">1460-9568</idno>
<imprint><publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2010-10">2010-10</date>
<biblScope unit="volume">32</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="1152">1152</biblScope>
<biblScope unit="page" to="1162">1162</biblScope>
</imprint>
<idno type="ISSN">0953-816X</idno>
</series>
<idno type="istex">317B8452C4821DA8B3C152129AE149B83836055B</idno>
<idno type="DOI">10.1111/j.1460-9568.2010.07421.x</idno>
<idno type="ArticleID">EJN7421</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0953-816X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>DBS</term>
<term>Parkinson’s disease</term>
<term>depression</term>
<term>enhancement</term>
<term>ethics</term>
<term>psychosurgery</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Deep brain stimulation (DBS) is a clinically established procedure for treating severe motor symptoms in patients suffering from end‐stage Parkinson’s disease, dystonia and essential tremor. Currently, it is tested for further indications including psychiatric disorders like major depression and a variety of other diseases. However, ethical issues of DBS demand continuing discussion. Analysing neuroethical and clinical literature, five major topics concerning the ethics of DBS in clinical practice were identified: thorough examination and weighing of risks and benefits; selecting patients fairly; protecting the health of children in paediatric DBS; special issues concerning patients’ autonomy; and the normative impact of quality of life measurements. In exploring DBS for further applications, additionally, issues of research ethics have to be considered. Of special importance in this context are questions such as what additional value is generated by the research, how to realise scientific validity, which patients should be included, and how to achieve an acceptable risk–benefit ratio. Patients’ benefit is central for ethical evaluation. This criterion can outweigh very serious side‐effects, and can make DBS appropriate even in paediatrics. Because standard test procedures evade central aspects of patients’ benefits, measuring quality of life should be supplemented by open in‐depth interviews to provide a more adequate picture of patients’ post‐surgical situation. To examine its entire therapeutic potential, further research in DBS is needed. Studies should be based on solid scientific hypotheses and proceed cautiously to benefit severely suffering patients without putting them to undue risks.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bade-Wurtemberg</li>
<li>District de Tübingen</li>
</region>
<settlement><li>Tübingen</li>
</settlement>
</list>
<tree><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Clausen, Jens" sort="Clausen, Jens" uniqKey="Clausen J" first="Jens" last="Clausen">Jens Clausen</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000727 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000727 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:317B8452C4821DA8B3C152129AE149B83836055B |texte= Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice }}
This area was generated with Dilib version V0.6.23. |